NEW CASTLE (April 22, 2024) – Lieutenant Governor Bethany Hall-Long and leaders from the Department of Health and Social Services (DHSS), along with partner community agencies, led a community response briefing on Monday to provide the latest outcome data and other information regarding the State’s efforts to support individuals struggling with substance use disorder in Delaware.

Organized by DHSS’ Division of Substance Abuse and Mental Health (DSAMH), these quarterly briefings aim to inform the public about the State’s ongoing work to reduce overdoses and respond to the opioid epidemic.

The event was opened by Delaware Lt. Governor Bethany Hall-Long, who highlighted her commitment to supporting people in Delaware struggling with substance use disorder and the providers who are the helpers in Delaware.

“As a public health nurse, I’m optimistic our efforts are having an impact on the opioid crisis here in Delaware. But the fact still remains that we have lost far too many Delawareans.” said Lt. Gov. Hall-Long, PhD, RN, research scientist and Chair of the Delaware Behavioral Health Consortium. “We’ve thrown the kitchen sink at this issue – and we are not stopping anytime soon. It has taken an all-hands-on-deck approach to get this far. As we continue forward, I want to thank the many grassroots advocates, nonprofits, state and local government agencies, our General Assembly, and especially, family members, for leaning in and collaborating on how to provide the best treatment, prevention, and recovery models for Delawareans.”

DSAMH Director Joanna Champney followed the Lt. Governor and provided information on her office’s efforts to combat overdose fatalities and the harmful impacts of substance use disorder in the community.

“We will not rest until drug poisoning and overdose deaths in our state are at zero, but we are grateful for the efforts of all of our partners to continue flattening the curve,” said Director Champney. “We will continue to focus on our strategies of reducing the negative stigma of addiction, screening individuals for opioid use disorder, offering information to healthcare providers about how to use medication to treat opioid use disorder, blanketing the state with the overdose reversal medication, targeting efforts to reach specific consumer groups, and focusing on Delaware’s addiction treatment infrastructure.”

John Evans, Director of the Division of Forensic Science, spoke about the variety of substances leading to overdose fatalities and broke down some data that demonstrated usage in the state.

Caroline Judd, MPH, Substance Use Disorder Epidemiologist with the Division of Public Health, shared data from the State Unintentional Drug Overdose Reporting System (SUDORS) as well as other key data points related to non-fatal overdose. The links below will provide access to the full sets of data provided by Caroline Judd during the press briefing:

State Unintentional Drug Overdose Deaths, Delaware, 2018 to 2022 (arcgis.com)

Non-Fatal Emergency Visits, Delaware, 2019 to 2024 (arcgis.com)

Kim Blanch, BSN, RN, Director of Community Outreach at Beebe Healthcare, and Arlene Wood, LPCHM, LCPC, NCC, Beebe Healthcare Behavioral Health Grant Director, provided detailed insight from the provider perspective of their community work. Beebe Healthcare also brought their mobile outreach vehicle and provided tours for the public in attendance to see how they perform their work in the community.

Dr. Robert Rosenbaum, M.D., FACEP, FAEMS/State Medical Director for Emergency Medical Services and Preparedness at the Division of Public Health, spoke about the use of Buprenorphine by EMS response teams as a way to save lives and serve the public.

To help address behavioral health needs of Delawareans, DHSS has several ways for individuals or their family members to connect:

• Call the 24/7 Delaware Hope Line at 1-833-9-HOPEDE or 1-833-946-7333 – a single point of contact in which callers can connect to a variety of resources and information, including support from clinicians and peer specialists plus crisis assistance.
• Stop by one of DHSS’ Bridge Clinics for an in-person assessment.
• Visit TreatmentConnection.com to find out which treatment providers are located near you.
• Visit HelpIsHereDE.com, DHSS’ one-stop website where Delawareans can search for treatment services and resources in Delaware or nearby states.
• Call 988 if the individual is in crisis and needs immediate support.
• Call 911 if someone has overdosed and needs emergency medical attention.
• Learn where to find Narcan training, get the medication through the mail, and download the OpiRescueDE App here.

On April 9, 150 Delaware Cancer Consortium (DCC) members gathered for their 2024 retreat for presentations by prominent local and national speakers, including four cancer survivors who shared their diagnosis, care, and experience living with cancer.

The theme was Vision. Purpose. Action. Coming Together to Eliminate Cancer Disparities, aligning with DCC’s goal to implement culturally inclusive initiatives that ensure affordable and accessible care.

The Delaware General Assembly established the DCC in 2001 to reduce Delaware’s cancer incidence and mortality rates. Over the past 23 years, the DCC has produced five five-year plans with innovative cancer control recommendations that guide its members and thousands of dedicated volunteers.

“Every year, this event renews our passion to give Delawareans the resources they need to lead healthy lives,” said Governor John Carney. “Since the mid-to-late 1990s, Delaware’s cancer mortality rate has decreased substantially. We still have work to do, but thanks to the dedication of our health care workers and the Delaware Division of Public Health, we are on the right track.”

In the 1990s, Delaware’s cancer death rate ranked second in the nation. Most recent data show the state ranks 15th in cancer mortality and 20th for cancer incidence rate (457.6 per 100,000 in Delaware compared to 442.2 per 100,000 population in the nation), according to the Delaware Cancer Registry for the period 2016-2020.

Since the creation of the Delaware Cancer Treatment Program in 2004, funding for cancer treatments has been provided to 2,009 Delaware residents as of March 30, 2024.

• 13,019 Delaware residents were enrolled in the Screening for Life program between calendar years 2017 and 2023, and 8,303 received free breast, cervical, colorectal, lung, or prostate cancer screenings during that time period.
• The Screening for Life program was created in 1997 and expanded by the Delaware Cancer Consortium in 2002. The program began covering lung cancer screenings in 2015.
• Each year, the Screening for Life program provides free breast and cervical cancer screenings to over 1,000 women.

Governor Carney and Lieutenant Governor Bethany Hall-Long signed two proclamations that designate the month of April as Cancer Control Month and Minority Cancer Awareness Month.

The Cancer Control Month designation urges all Delawareans to get screened for cancer when advised to do so and encourages all health care providers to promote cancer screening “as a powerful opportunity to save lives.”  Regular screenings increase the odds of detecting cancer in the early stages, when it is most treatable.  It remains a top priority for the DCC to ensure Delawareans have access to regular screenings and know the recommended guidelines.

According to the Delaware Cancer Registry for the period 2016-2020, 22.4% of new cancer cases in Delaware were detected in the distant stage, compared to 48.3% diagnosed at the local, or early, stage.

“I’m just going to be candid: knowing your cancer risk – as early as possible – can literally be the difference between life and death,” said Lieutenant Governor Hall-Long, who serves on two DCC committees. “The DCC is working tirelessly to raise awareness and increase accessibility to detect and treat cancer for all Delawareans. We have work to do, but I commend these continued efforts.”

The DCC and the Division of Public Health’s Bureau of Cancer Prevention and Control work to ensure every Delawarean has access to timely cancer screenings and treatment through the Screening for Life (SFL) Program and the Delaware Cancer Treatment Program.  Cancer screenings are covered by insurance or SFL.  Delawareans can determine their eligibility for SFL by visiting Healthy Delaware.org or calling the SFL Program at 302-744-1040.

In a nod to pursing full health equity, the Minority Cancer Awareness Month observance notes that cancer disproportionately affects Delaware’s minority communities and urges them to get cancer screenings when advised to do so.

According to the Delaware Cancer Registry, for the period 2016-2020, the all-site cancer mortality rate among non-Hispanic Black Delawareans (171.7 people per 100,000 population) was higher than for non-Hispanic White Delawareans (158.9 people per 100,000 population).

In the 2020 Behavioral Risk Factor Survey, 36% of non-Hispanic White Delawareans reported having a PSA test to detect prostate cancer in the past two years compared to 26% of non-Hispanic Black Delawareans.  For 2016-2020, 28.3% of new breast cancer cases were detected in the distant stage among non-Hispanic White Delawareans, compared to 36.7% diagnosed at the distant stage among non-Hispanic Black Delawareans, according to the Delaware Cancer Registry.

Elle Sheaffer, a five-year cancer survivor of Newark and distinguished speaker at the retreat, is now a DBCC volunteer and leads a flower-arranging course for Cancer Support Community.

“A lot of people are scared to get help and think they must do it alone, but these resources are here, and they are still helping me thrive,” said Sheaffer.

For more information on the DCC’s initiatives, committees, upcoming events, and the current five-year plan, visit healthydelaware.org/consortium.

DOVER, DE (Jan. 3, 2023) – Through the Centers for Disease Control and Prevention’s State Unintentional Drug Overdose Reporting System (SUDORS), Delaware was recently among 47 states to contribute data to the CDC’s Dec. 16, 2022, Morbidity and Mortality Weekly Report, titled “Drug Overdose Deaths Among Persons Aged 10-19 Years – United States, July 2019-December 2021.” The Division of Public Health (DPH) utilizes SUDORS to track available trends and characteristics of drug overdose deaths and inform prevention and response efforts.

Although middle school and high school aged youth in the U.S. reported using fewer illicit drugs in 2020, there was a 94% increase in overdose deaths from 2019 to 2020 among this age group and a 20% increase from 2020 to 2021, according to the CDC report. From July-December 2019 to July-December 2021, the median monthly overdose deaths increased 109%. Despite reporting less illicit drug use among this population overall, the CDC points to the potency of the drugs as a major contributing factor to the increase in overdose deaths among youth. During the same time period, deaths involving illicitly manufactured fentanyl increased 182%. Approximately 90% of overdose deaths involved opioids, and 83.9% involved illicit manufactured fentanyl.

Most youth who overdosed had no prior opioid use history, according to the CDC. Approximately a quarter of the deaths included evidence of counterfeit pills. However, this data may be underreported. The United States Drug Enforcement Administration has documented counterfeit pills laced with fentanyl being sold to youth through social media. DPH has responded with an educational fentanyl campaign targeted to youth stating, “If you get your drugs from a DM and not a doctor, odds are they’re laced with fentanyl.” This campaign is running on various social media platforms. 

Additionally, two-thirds of decedents had a potential bystander present, although most provided no overdose response. It is important that family and friends recognize the warning signs of drug use and respond quickly to an overdose. The CDC states that parents should monitor adolescent behavior. DPH and the Division of Substance Abuse and Mental Health developed the toolkit, Talk2Kids About Drugs, which is available on HelpIsHereDE.com. This toolkit has resources for parents and educators on how to talk to kids about drugs and alcohol. In addition, DPH has worked with the Department of Education on new health modules for high schoolers on drug prevention and education. However, more opportunities for opioid response including Narcan administration training for parents, staff, and youth ages 14 and older is needed so that Narcan is readily available.

The CDC states that roughly 41% of decedents had a history of a mental health condition or treatment for substance use disorder. It is important that the community supports youth by implementing programs to prevent adverse childhood experiences. The Division of Public Health created the #MyReasonWhyDE campaign so that youth can promote their reason to remain drug free and embrace a resilient mind frame. However, if youth are struggling with their mental health or substance use disorder, there are resources available on HelpIsHereDE for immediate treatment in person, by phone or text, or online. Crisis intervention services for children under 18 are available 24/7 for parents and caregivers at 800-969-4357 or by texting DE to 741-741. 

If you or a loved one is struggling with addiction in Delaware, call the DHSS 24/7 Crisis Hotline to be connected to treatment and recovery options. In New Castle County, call 1-800-652-2929. Or in Kent and Sussex counties, call 1-800-345-6785. For free 24/7 counseling, coaching, and support, as well as links to mental health, addiction, and crisis services call the Delaware Hope Line at 1-833-9-HOPEDE. To search for treatment and recovery services in Delaware or nearby states, visit HelpIsHereDE.com. 

### 

The Delaware Division of Public Health (DPH), a division of the Delaware Department of Health and Social Services, is a nationally accredited public health agency recognized by the Public Health Accreditation Board for its outstanding dedication to driving change through innovation. DPH is committed to improving the quality of the lives of Delaware’s citizens by promoting health and well-being, fostering self-sufficiency, and protecting vulnerable populations. 
  

Anyone who is deaf, hard of hearing, Deaf-Blind, or speech-disabled can contact DPH by first dialing 711 using specialized devices (i.e., TTY, TeleBraille, voice devices). The 711 service is free; to learn more about how it works, visit delawarerelay.com.  

WILMINGTON, Del. – Governor Carney on Thursday formally extended the Public Health Emergency order another 30 days to allow the State of Delaware and medical providers to continue COVID-19 vaccination and testing programs.

“It’s important that we keep doing the things we know that work,” said Governor Carney. “Stay home if you’re sick and get tested. Get vaccinated and boosted when you’re eligible. I’d also encourage all eligible Delawareans to get a flu shot to prepare for flu season.”

Under Delaware law, Public Health Emergency declarations must be renewed every 30 days.

Visit Governor Carney’s website to view the Public Health Emergency extension.

###

DOVER, DE (July 21, 2022) ­– The Delaware Division of Public Health (DPH) is announcing the state’s second and third cases of the monkeypox virus (MPX). Both cases are considered probable pending confirmatory testing by the Centers for Disease Control and Prevention (CDC).

This week, DPH received test results showing that a 46-year-old Sussex County man tested positive for MPX. The patient did not report any travel, and first reported symptoms on July 18. DPH is working to contact the patient to inform them about treatment options and interview them to obtain a list of possible contacts.

Additionally, DPH received test results this week showing that a 25-year-old Kent County man tested positive for MPX. The patient did not report any travel, and first reported symptoms on July 14. The patient has been advised to self-isolate until lesions have fallen off and new skin appears. 

“The overall risk to the public is low and remains low,” said DPH Interim Director Dr. Rick Hong. “MPX is transmitted through close intimate contact with individuals who have rashes or flu-like symptoms. We urge people to educate themselves about this rare disease, including how it is spread, and to help prevent exposure. DPH will continue to work with medical providers to screen and identify individuals for MPX testing. And we will prioritize our limited supply of vaccine for people who have been exposed to MPX ​for post-exposure prophylaxis (PEP).”

Beginning July 21, DPH will operate a hotline for individuals with specific concerns because of symptoms or possible exposure. The hotline number is 866-408-1899 and the number will operate with the following hours: 

• Monday – Friday from 8:30 a.m. to 4:30 p.m.

Currently, there is no specific treatment for the monkeypox virus infection​; however, antivirals, can be prescribed. DPH has received a limited supply of the vaccine, which needs to be given in two doses 28 days apart. Those who are at the highest risk of exposure to the virus include:

• People who have been identified as a contact of someone with MPX
• People who are aware that one of their sexual partners in the past two weeks was diagnosed with MPX
• People who had multiple sexual partners in the past two weeks in an area with known MPX

Until spring 2022, MPX cases were rare in the United States. Today, there are more than 2,300 cases nationwide, with Delaware announcing its first case on July 12, 2022, involving a 41-year-old New Castle County patient.

Signs and Symptoms

The symptoms of MPX are similar to but milder than the symptoms of smallpox. Symptoms usually start within three weeks of exposure to the virus. Most people who contract MPX will develop a rash, and some will develop flu-like symptoms beforehand. The flu-like symptoms may include fever, headache, muscle aches and backache, sore throat, cough, swollen lymph nodes, chills, or exhaustion. If someone has flu-like symptoms, they usually will develop a rash one to four days later.

If you suspect you are experiencing any symptoms associated with MPX you should immediately:

• Contact your health care provider and discuss your symptoms and concerns.
• Self-isolate until all lesions have resolved, the scabs have fallen off, and a fresh layer of intact skin has formed.
• Avoid being intimate with others.
• Make a list of your close and intimate contacts in the last 21 days.

To prevent infection with MPX:

• Avoid close, skin-to-skin contact with people who have a rash that looks like MPX.
• Do not touch the rash or scabs of a person with MPX.
• Do not kiss, hug, cuddle or have sex with someone with MPX.
• Do not share eating utensils or cups with a person with MPX.
• Do not handle or touch the bedding, towels, or clothing of a person with MPX.
• Wash your hands often with soap and water or use an alcohol-based hand sanitizer.

To learn more about MPX management and prevention programs and resources, visit https://dhss.delaware.gov/dph/epi/emerginginfectiousdiseases.html.